🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Chronic Obstructive Pulmonary Disease (COPD) is currently the fourth leadin...
Status
Completed
Location
Shenjing Hospital
Start Date
2019-08-30
Trial ID
NCT03851991
The most important treatment for AR is topical nasal medications (including...
Status
Recruiting
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & Technology
Start Date
2024-07-11
Trial ID
NCT06462417
Treatments Being Tested
This is Phase 2 multi-center controlled randomized study to assess the effi...
Status
Completed
Location
NRC Institute of Immunology FMBA
Start Date
2021-04-27
Trial ID
NCT05184127
Treatments Being Tested
The study explores the efficacy of lopinavir plus ritonavir and arbidol in ...
Status
Completed
Location
Guangzhou Eighth People's Hospital
Start Date
2020-01-28
Trial ID
NCT04252885
Treatments Being Tested
The purpose of this study is to determine whether Arbidol (Umifenovir) is e...
Status
Unknown
Location
Research Institute of Influenza
Start Date
2011-09
Trial ID
NCT01651663
Treatments Being Tested
The novel coronavirus infectious disease ( COVID-19") induced by novel coro...
Status
Unknown
Location
Multiple Locations
Start Date
2020-02-23
Trial ID
NCT04286503
Treatments Being Tested
Randomized open-label multicenter parallel-group study of efficacy and safe...
Status
Completed
Location
Medical center LLC "Neuroprofi"
Start Date
2020-05-20
Trial ID
NCT04501783
Treatments Being Tested
The aim of this study is to evaluate the effectiveness and safety of MIR 19...
Status
Completed
Location
NRC Institute of Immunology FMBA
Start Date
2022-02-10
Trial ID
NCT05783206
Treatments Being Tested
A single dose of Reference product containing 200 mg umifenovir hydrochlori...
Status
Unknown
Location
Novagenix Drug R&D Center
Start Date
2020-07-09
Trial ID
NCT04476719
Treatments Being Tested